Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

Journal of Neural Transmission

Volumn 104, Issue 6-7, 1997, Pages 661-677

  Pearce, R K B ^a,b   Owen, A ^a   Daniel, S ^b   Jenner, P ^a   Marsden, C D ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Glutathione; Oxidative stress; Parkinson's disease; Substantia nigra

Indexed keywords

FLUORESCENT DYE; GLUTATHIONE;

AGED; ARTICLE; ASTROCYTE; CAPILLARY WALL; CELL NUCLEUS; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; MICROGLIA; NERVE CELL; NERVE DEGENERATION; NEUROPIL; OXIDATIVE STRESS; PARKINSON DISEASE; PERIKARYON; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORING AGENTS; FEMALE; GLUTATHIONE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, FLUORESCENCE; PARKINSON DISEASE; PHENYLMERCURY COMPOUNDS; SUBSTANTIA NIGRA;

EID: 0030724621     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01291884     Document Type: Article

References (42)

1. Amara A, Coussemacq M, Geffard M (1994) Antibodies to reduced glutathione. Brain Res 659: 237-242
2. Asghar K, Reddy BG, Krishna G (1975) Histochemical localisation of glutathione in tissues. J Histochem Cytochem 23: 774-779
3. Benzi G, Pastoris O, Marzatico F, Villa RF (1992) The mitochondrial electron transfer alteration as a factor involved in the aging brain. Neurobiol Aging 12: 361-368
4. Bridges RJ, Koh J-Y, Hatalski CG, Cotman CW (1991) Increased excitotoxic vulnerability of cortical cultures with reduced levels of glutathione. Eur J Pharmacol 192: 199-200
5. Chau RMW, Skaper SD, Varon S (1988) Peroxidative block of glucose utilization and survival in CNS neuronal cultures. Neurochem Res 13: 611-616
6. Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F (1993) Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52: 1-6
7. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Jenner P, Marsden C (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurogedenerative disease affecting the basla ganglia. Brain 114: 1953-1975
8. Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Danial SE, Lees AJ, Schapira AHV, Jenner P, Marsden CD (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 35: 38-44
9. Di Monte DA, Chan P, Sandy MS (1992) Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage? Ann Neurol 32: S111-S115
10. Fearnley JM, Lees AJ (1991) Aging and Parkinson's disease: substantia nigra regional selectivity. Brain 114: 2283-2301
11. Forno LS (1969) Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases). Relationship to parkinsonism. J Am Geriatr Soc 17: 557-575
12. Gibb WRG (1986) Idiopathic Parkinson's disease and the Lewy body disorders. Neuropathol Appl Neurobiol 12: 223-234
13. Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51: 745-752
14. Man S-K, Mytilineou C, Cohen G (1996) L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J Neurochem 66: 501-510
15. Heafield TH, Fearn S, Steventon GB, Waring RH, Williams AC, Sturman SG (1990) Plasma cysteine and sulphate levels in patients with motor neurone. Parkinson's and Alzheimer's disease. Neurosci Lett 110: 216-220
16. Hjelle OP, Chaudhry FA, Ottersen OP (1994) Antisera to glutathione: characterization and immunocytochemical application to the rat cerebellum. Eur J Neurosci 6: 793-804
17. Huang J, Philbert MA (1995) Distribution of glutathione and glutathione-related enzyme systems in mitochondria and cytosol of cultured cerebellar astrocytes and granule cells. Brain Res 680: 16-22
18. Jain A, Martensson J, Stole E, Auld PAM, Meister A (1991) Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci USA 88: 1913-1917
19. Jenner P, Dexter DT, Sian J, Schapira AHV, Marsden CD (1992) Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann Neurol 32: 582-587
20. Jenner P, Schapira AHV, Marsden CD (1992) New insights into the cause of Parkinson's disease. Neurology 42: 2241-2250
21. Kirstein CL, Coopersmith R, Bridges RJ, Leon M (1991) Glutathione levels in olfactory and non-olfactory neural structures of rats. Brain Res 543: 341-346
22. Makar TK, Nefergaard M, Preuss A, Gelbard AS, Perumal AS, Cooper AJL (1994) Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J Neurochem 62: 45-53
23. Marttila RJ, Lorentz H, Rinne UK (1988) Oxygen toxicity protecting enzymes in Parkinson's disease: increase of Superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci 86: 321-331
24. McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988) Rate of cell death in parkinsonism indicates an active neuropathological process. Ann Neurol 24: 574-576
25. McGeer PL, Kawamata T, Douglas GW, et al (1993) Microglia in degenerative neurological disease. Glia 7: 84-92
26. Meister A (1992) On the antioxidant effects of ascorbic acid and glutathione. Biochem Pharmacol 44: 1905-1915
27. Meister A (1995) Mitochondrial changes associated with gluthatione deficiency. Biochim Biophys Acta 1271: 35-42
28. Perry TL, Yong VW (1986) Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 67: 269-274
29. Perry TL, Godwin DV, Hansen S (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency. Neurosci Lett 33: 305-310
30. Philbert MA, Beiswanger CD, Waters DK, Reuhl KR, Lowndes HE (1991) Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localisation by mercury orange and O-phthaldialdiadehyde-induced histofluorescence. Toxicol Appl Pharmacol 107: 215-227
31. Pileblad E, Fornstedt B, Magnusson T (1989) Reduction of brain glutathione by L-buthione sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum. J Neurochem 52: 978-980
32. Pileblad E, Erikksson PS, Hansson E (1991) The presence of glutathione in primary neuronal and astroglial cultures from rat cerebral cortex and brain stem. J Neural Transm 86: 43-49
33. Raps SP, Lai JCK, Hertz L, Cooper AJL (1989) Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res 493: 398-401
34. Riederer P, Sofie E, Rausch W-D, Schmidt B, Reynolds GB, Jellinger K, Youdim MBH (1989) Transition metals, ferritin. glutathione and ascorbic acid in parkinsonian brains. J Neurochem 52: 515-520
35. Sagara J, Miura K, Bannai S (1993) Maintenance of neuronal glutathione by glial cells. J Neurochem 61: 1672-1676
36. Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD (1989) A selective increase in particulate Superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 53: 692-697
37. Schapira AHV, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990) The anatomic and disease specificity of NADH CoO reductase (complex I) deficiency in Parkinson's disease. J Neurochem 55: 2142-2145
38. Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting the basal ganglia. Ann Neurol 36: 348-355
39. Sian J, Dexter DT, Lees AJ, Jenner P, Marsden CD (1994) Glutathione-related enzymes in brain in Parkinson's disease. Ann Neurol 36: 356-361
40. Slivka A, Mytilineou C, Cohen G (1987) Histochemical evaluation of gluthathione in brain. Brain Res 409: 275-284
41. Wafers H, Sies H (1988) The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. Eur J Biochem 174: 353-357
42. Zängerle L, Cuénod M, Winterhalter KH, Do KQ (1992) Screening of thiol compounds: depolarization-induced release of glutathione and cysteine from rat brain slices. J Neurochem 59: 181-189